Invention Grant
- Patent Title: Lyophilized formulations of tegavivint
-
Application No.: US17103468Application Date: 2020-11-24
-
Publication No.: US11571388B2Publication Date: 2023-02-07
- Inventor: Gowri Sukumar , Drazen Ostovic
- Applicant: Iterion Therapeutics, Inc.
- Applicant Address: US TX Houston
- Assignee: Iterion Therapeutics, Inc.
- Current Assignee: Iterion Therapeutics, Inc.
- Current Assignee Address: US TX Houston
- Agency: Wood, Phillips, Katz, Clark & Mortimer
- Main IPC: A61K9/19
- IPC: A61K9/19 ; A61K9/16 ; A61K31/4545
Abstract:
Lyophilized formulations of tegavivint, methods of making such formulations, and methods of treatment of cancer by administering the formulations.
Public/Granted literature
- US20220160635A1 LYOPHILIZED FORMULATIONS OF TEGAVIVINT Public/Granted day:2022-05-26
Information query
